Pathological complete response - Globe Thesis

Keyword [Pathological complete response] Result: 41 - 60 \| Page: 3 of 5
41.	Efficacy And Long-term Survival Outcomes Of Dose-dense Carboplatin Plus Paclitaxel As Neoadjuvant Chemotherapy For Triple-negative Breast Cancer
42.	Correlation Analysis Of Hormone Receptor And Response To Neoadjuvant Chemotherapy In Breast Cancer And Construction Of A Predictive Model
43.	A Meta-analysis Of The Effect Of Immunotherapy Plus Neoadjuvant Chemotherapy On Triple Negative Breast Cancer
44.	Analysis Of Related Clinical Biological Indicators For Predicting Pathological Complete Response After Neoadjuvant Chemotherapy In Breast Cancer
45.	The Predictive Value Of Systemic Immunoinflammatory Index And Tumor-infiltrating Lymphocytes On The Efficacy Of Neoadjuvant Chemotherapy In Locally Advanced HER-2 Positive Breast Cancer
46.	Correlation Between MRI Signs And NAC Efficacy Before Neoadjuvant Chemotherapy In Breast Cancer
47.	Correlation Analysis Of Axillary Lymph Node Status After Neoadjuvant Chemotherapy For Breast Cancer
48.	Analysis Of Related Factors Of Pathological Complete Response To Neoadjuvant Therapy In Patients With HER-2 Positive Invasive Breast Cancer
49.	Correlation Analysis Of Microcalcification Changes With Pathological Complete Response After Neoadjuvant Chemotherapy In Breast Cancer
50.	Predictive Value Of Systemic Inflammatory Response Index On The Efficacy Of Neoadjuvant Chemotherapy In Breast Cancers Patients
51.	Value Of MRI Morphological, Clinicopathological And Textural Features In Predicting The Efficacy Of Neoadjuvant Chemoradiotherapy In Rectal Cancer
52.	Prediction Of Treatment Response To Neoadjuvant Therapy Based On Longitudinal Ultrasound Images Of Breast Cancer Patients By Deep Learning Techniques
53.	Prognostic Value Of Residual Tumor/Scar And Recurrence Pattern For Patients With Locally Advanced Rectal Cancer After Neoadjuvant Chemoradiotherapy
54.	Research On Efficacy And Molecular Biomarkers In Neoadjuvant Therapy For Breast Cancer
55.	The Exploration Of Personalized Therapeutic Strategy And Promising Biomarkers For Patients With Triple-negative Breast Cancer
56.	Exploratory Study Of Different Molecular Markers On The Predictive And Prognostic Value Of Neoadjuvant Chemotherapy In Breast Cancer
57.	Influencing Factors And Predictors Of Effect Of Pathological Complete Response Of HER2-positive Breast Cancer Treated With Neoadjuvant Treatment And Mechanism Of Drug Resistance
58.	Predictive Model Construction And Analysis Of Pathological Complete Response After Neoadjuvant Chemotherapy Of Breast Cancer
59.	SPARC MRNA Predicts The Efficacy Of Nab-Paclitaxel In The Treatment Of Malignant Tumors
60.	Cost-effectiveness Analysis Of Neoadjuvant Therapy And Clinical Efficacy Evaluation For Breast Cancer
<<First <Prev Next> Last>> Jump to